Board of Directors

Management | Board of Directors | Committee Composition | Charters & Policies
  • Biography PhotoJeff DykanChairperson

    Jeff Dykan has served on the ReWalk board since 2006 and has been its Chairman since 2009. Mr. Dykan has been a director of the corporate general partner of the common general partner of Vitalife and its successor fund, SCP Vitalife, an Israeli venture capital fund, since 2002 and 2007, respectively. Prior to joining Vitalife, from 2001 to 2002, Mr. Dykan was the Chairman and Chief Executive Officer of BitBand Inc. Mr. Dykan is a member of the American Institute of CPAs and holds a B.Sc. in accounting and management and an MBA in computer applications, both from New York University.

  • Biography PhotoLarry JasinskiCEO & Director

    Larry Jasinski has served as Chief Executive Officer and as a member of the ReWalk board since February 2012. From 2005 until 2012, Mr. Jasinski served as the President and Chief Executive Officer of Soteira, Inc., a company engaged in development and commercialization of products used to treat individuals with vertebral compression fractures, which was acquired by Globus Medical in 2012. From 2001 to 2005, Mr. Jasinski was President and Chief Executive Officer of Cortek, Inc., a company that developed next-generation treatments for degenerative disc disease, which was acquired by Alphatec in 2005. From 1985 until 2001, Mr. Jasinski served in multiple sales, research and development, and general management roles at Boston Scientific Corporation. Mr. Jasinski holds a B.Sc. in marketing from Providence College and an MBA from the University of Bridgeport.

  • Biography PhotoArik DanDirector

    Aryeh (Arik) Dan has served on the ReWalk board since 2013. He has served as the President and Chief Executive Officer of Yaskawa Europe Technology since 2005. Mr. Dan holds a B.Sc. in aeronautical engineering from the Technion—Israel Institute of Technology and an MBA from Keio University, Japan.

  • Biography PhotoYasushi IchikiDirector

    Yasushi Ichiki has served on the ReWalk board since 2014. Mr. Ichiki has been the Manager of the Corporate Planning Group, Corporate Planning Division, of Yaskawa Electric Corporation since May 2014. Previously, from February 2010 to April 2014, he served as the General Manager of Corporate Planning, Robotics Division of Yaskawa Europe GmbH. Mr Ichiki holds a B.A. from Yamaguchi University, Japan.

  • Biography PhotoGlenn MuirDirector

    Glenn Muir has served on the ReWalk board since July 2014 as an external director. Until May 2014, Mr. Muir served as Executive Vice President, Finance and Administration of Hologic, Inc. (NASDAQ: HOLX) since September 2000 and as Chief Financial Officer since 1992. Hologic is a manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products with an emphasis on serving the healthcare needs of women. Prior to that, Mr. Muir served as the Controller of Hologic from the time he joined in October 1988 through 1992 including during its initial public offering in 1990. Mr. Muir served as a director of Hologic from 2001 through 2013. Mr. Muir holds a B.B.A. with a major in accounting from the University of Massachusetts in Amherst, an M.B.A. from the Harvard Graduate School of Business Administration and an M. Sc. in taxation from Bentley College Graduate School of Business. Mr. Muir is also a certified public accountant.

  • Biography PhotoWayne B. WeismanDirector

    Wayne B. Weisman has served on the ReWalk board since 2009. Since 2007, Mr. Weisman has been a director of the corporate general partner of the common general partner of SCP Vitalife. He has also served as a managing member of SCP Vitalife Management Company, LLC, which by contract provides certain management services to the common general partner of SCP Vitalife. Mr. Weisman is Chairman of Recro Pharma, Inc. (Nasdaq: REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain. He also serves on the board of a number of private companies, including Recro Pharma, LZ Therapeutics and Echo 360. He is Chairman of the board of trustees of Young Scholars School. Mr. Weisman holds a B.A. from the University of Pennsylvania and a J.D. from the University of Michigan Law School.

  • Biography PhotoDr. John William PoduskaDirector

    Dr. John William Poduska will serve on the ReWalk board starting in September 2014 as an external director. Dr. Poduska currently serves as a director of EXA Corporation (NASDAQ: EXA) where he serves as chairman of the compensation committee and a member of the nominating and governance committee. He also serves as a director on the boards of a number of privately-held companies. Dr. Poduska also served as a director of Novell, Inc. until 2011 and of Anadarko Petroleum Corporation and Safeguard Scientifics, Inc. until 2009. Dr. Poduska was the Chairman of Advanced Visual Systems Inc., a provider of visualization software, from January 1992 to December 2001. From December 1989 until December 1991, Dr. Poduska was President and Chief Executive Officer of Stardent Computer Inc., a computer manufacturer. From December 1985 until December 1989, Dr. Poduska served as Chairman and Chief Executive Officer of Stellar Computer Inc., a computer manufacturer he founded which is the predecessor of Stardent Computer Inc. Prior to founding Stellar Computer, Inc., Dr. Poduska founded Apollo Computer Inc. and Prime Computer, Inc. Dr. Poduska holds a Sc.D. from MIT and an Honorary Doctorate of Humane Letters from Lowell University.

  • Biography PhotoDeborah DiSanzoDirector

    Deborah DiSanzo is an innovative, strategic, internationally experienced executive who has managed both large and small global medical technology and informatics businesses.  Ms. DiSanzo was the Chief Executive Officer of Philips Healthcare, a $10 billion euro healthcare technology company providing technology in healthcare informatics, patient monitoring and patient analytics, home healthcare, imaging systems, and healthcare consulting.  Ms. DiSanzo addressed crucial issues in the rising incidence of chronic conditions, aging population, care provider shortages, and escalating healthcare costs with innovations that span the care continuum.  She was a pioneer in the field of Automated External Defibrillators, and she was instrumental in introducing the industry’s first AED designed specifically for use by the lay public.

    An influential community and business leader, Ms. DiSanzo is a board member and member of the audit committee of Project Hope, a NGO dedicated to providing lasting solutions to health problems in underserved areas of the world. She is also a board member of Embrace Innovations, a social enterprise working to help millions of vulnerable babies through its revolutionary infant warmers.  Ms. DiSanzo was awarded the American Heart Association’s Cor Vitae award for creative volunteerism, public education, community involvement, and $1M in fundraising.

    Ms. DiSanzo chaired the World Economic Forum’s steering board for the project on Health Systems Leapfrogging in Emerging Economies.   She was listed among the Top 100 women-led businesses in Massachusetts in 2013 by the Boston Globe and the Commonwealth Institute and was named one of the Inspiring Fifty, honoring women in business and high technology in the Netherlands.  She earned a Master’s of Business Administration from Babson College, and a Bachelor of Science from Merrimack College. Ms. DiSanzo was inducted into the Babson Alumni Entrepreneur Hall of Fame, and received Babson’s Founder’s Day Award for Entrepreneurship.

  • Biography PhotoPete WehrlyDirector

    Pete Wehrly previously served in multiple senior roles at Covidien plc (“Covidien”), including Group President of Developed Markets and Group President of Respiratory & Monitoring Solutions and Vascular Therapies, from 2009 until 2015, during which Covidien was a public company listed on the New York Stock Exchange. Prior to joining Covidien, Pete served as President and Chief Executive Officer at Medingo Ltd. an Israel based company from 2008-2009. From 2000 to 2008 he held senior executive-level roles at Medtronic Spinal and Biologics in Memphis, Tennessee, where he oversaw the global market expansion of that company’s core spinal fusion therapies, minimal access technologies, motion-sparing devices and biologic technologies. Prior to that, he spent 17 years at DePuy, a division of Johnson & Johnson, and served as DePuy’s Sports Medicine Division President from 1997 to 2000. Throughout his career at various companies, Pete headed regional strategies to gain regulatory approval and reimbursement for new technologies in Europe, Japan, Australia, New Zealand, the United States and Canada. In addition, since 2012, he has been a director of Non Linear Technologies Ltd. Pete holds a Bachelor of Science in Management from Ball State University in Muncie, Indiana and has been a member of a number of community boards.